Expert team
home > Expert team > list page
Jaishree Jagirdar MD 2015-04-20
Dr. Jagirdar is currently Professor of Pathology and Director of Anatomic Pathology at University of Texas Health Science Center. She is an internationally recognized pulmonary pathologist with 37 years of experience.
Eric Duncavage 2015-10-13
Eric Duncavage is an assistant professor of anatomic and molecular pathology at Washington University in St. Louis. He completed his AP/CP residency and MGP fellowship at Washington University in St. Louis followed by a hematopathology fellowship at ARUP Reference Laboratory and is board-certificated in anatomic pathology, clinical pathology, hematopathology, and molecular diagnostic pathology.
Dr. Ping Tan 2015-04-14
Dr. Ping Tang is Professor of Pathology at University of Rochester Medical Center. Dr. Tang is a surgical pathologist with a subspecialty interest in breast pathology. Her educational background includes a research fellowship at Harvard Medical School, a PhD from MD Anderson Cancer Center in Houston Texas and a Fellowship in Surgical Pathology from Yale-New Haven Hospital in Connecticut. Dr. Tang’s impressive career has yielded extensive research publications and her current appointment at URMC. Her current research focuses on the use of immunocytochemical analysis to identify breast tumors with a high risk for bone metastasis. This presentation will discuss the selective expression of Folate Receptor alpha (FRA) in breast cancer: in particular the IHC expression of FRA in invasive ductal carcinoma (IDC) and in situ ductal carcinoma (DCIS).
Dr. Michael C. Dugan 2015-03-04
Dr. Michael C. Dugan is the Chief Medical Officer at bioTheranostics, Inc. in San Diego, CA. He has served as assistant professor of pathology at both UCLA and Wayne State University School of Medicine. Dr. Dugan earned his bachelor’s degree in biology from the University of Notre Dame and his medical degree from the University of Arizona College of Medicine. He completed postgraduate training at Yale-New Haven Hospital, Children’s Hospital Los Angeles, and UCLA. “Understanding the Importance of Molecular Classification as a Complementary Tool to IHC in Difficult-to-Diagnose Metastatic Cancer”
Dr. Dongfeng Tan 2015-01-11
“Molecular Diagnostics and Personalized Medicine of Colorectal Cancer”
Related Category
Promotion Products
  • Partners
  • Links
USCAP  |   CAP  |   IAP  |   TPIS  |   ASC  |   CAP-ACP  |   ASIP  |   AMP  |   ASCP  |   CAPA  |  
Home  |  News  |  Journals  |  Cases  |  Lectures  |  Experts  |  Telepath  |  Research  |  Conferences  |  Job_Position  |  Books  |  Sponsors
2009-2015 All Rights Reserved GoPath Diagnostics, LLC.